PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.00%
Revenue growth of 9.00% while XRF.AX is flat. Bruce Berkowitz would check if a small edge can widen further.
8.77%
Gross profit growth of 8.77% while XRF.AX is zero. Bruce Berkowitz would see if minimal improvements could expand further.
75.69%
EBIT growth of 75.69% while XRF.AX is zero. Bruce Berkowitz would see if small gains can be scaled further.
75.69%
Operating income growth of 75.69% while XRF.AX is zero. Bruce Berkowitz would see if this modest edge can become significant.
77.97%
Net income growth of 77.97% while XRF.AX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
100.00%
EPS growth of 100.00% while XRF.AX is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
66.67%
Diluted EPS growth of 66.67% while XRF.AX is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
31.77%
Share change of 31.77% while XRF.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
9.28%
Diluted share change of 9.28% while XRF.AX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
311.99%
OCF growth of 311.99% while XRF.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
225.39%
FCF growth of 225.39% while XRF.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-87.28%
Negative 10Y revenue/share CAGR while XRF.AX stands at 12.69%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-74.73%
Negative 5Y CAGR while XRF.AX stands at 10.96%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-64.55%
Negative 3Y CAGR while XRF.AX stands at 26.58%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-74.79%
Negative 5Y OCF/share CAGR while XRF.AX is at 740.87%. Joel Greenblatt would question the firm’s operational model or cost structure.
321.80%
3Y OCF/share CAGR 1.25-1.5x XRF.AX's 274.10%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
-100.57%
Negative 10Y net income/share CAGR while XRF.AX is at 910.18%. Joel Greenblatt sees a major red flag in long-term profit erosion.
61.50%
Below 50% of XRF.AX's 198.61%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
93.84%
Below 50% of XRF.AX's 782.14%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.55%
AR growth of 38.55% while XRF.AX is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-7.33%
Inventory is declining while XRF.AX stands at 7.14%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
7.41%
Asset growth above 1.5x XRF.AX's 3.48%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-129.89%
We have a declining book value while XRF.AX shows 5.54%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.94%
SG&A growth of 5.94% while XRF.AX is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.